ORGS vs OPY: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

OPY has stronger fundamentals based on our AI analysis.

ORGS
Orgenesis Inc.
STRONG SELL
95%
Confidence
VS
OPY
OPPENHEIMER HOLDINGS INC
BUY
72%
Confidence

ORGS vs OPY Fundamental Comparison

Metric ORGS OPY
Revenue $1.0M $1.6B
Net Income $-48.2M $148.4M
Net Margin -4,653.6% 9.1%
ROE N/A 15.1%
ROA -3,565.1% 4.0%
Current Ratio 0.03x N/A
Debt/Equity N/A 0.00x
EPS $11.44 $13.04

Green = Better metric | Red = Weaker metric

View Full ORGS Analysis →
View Full OPY Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

ORGS vs AAPL OPY vs MSFT ORGS vs GOOGL OPY vs AMZN

ORGS vs OPY: Frequently Asked Questions

Is ORGS or OPY a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), OPY has stronger fundamentals. ORGS is rated STRONG SELL (95% confidence) while OPY is rated BUY (72% confidence). This is not investment advice.

How does ORGS compare to OPY fundamentally?

Orgenesis Inc. has ROE of N/A vs OPPENHEIMER HOLDINGS INC's 15.1%. Net margins are -4,653.6% vs 9.1% respectively.

Which stock pays higher dividends, ORGS or OPY?

ORGS has a dividend yield of N/A or no dividend while OPY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ORGS or OPY for long term?

For long-term investing, consider that ORGS has STRONG SELL rating with 95% confidence, while OPY has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ORGS vs OPY?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ORGS vs OPY, the AI consensus favors OPY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.